Like many scientists, Timothy Radstake, Vice President and Global Head of Immunology Discovery Research at AbbVie, can trace the trajectory of his career to groundbreaking moments when he realized something new was happening, leading to a path of discovery. For him, one such moment occurred twenty years ago when he witnessed the impact of a new treatment for patients with rheumatoid arthritis, a chronic autoimmune disease.

Watch this video to learn more about his efforts to drive innovation, address existing gaps, and improve the standard of care—ultimately enhancing people's quality of life.